The Klotho and disease-related with thyroid glands
DOI:
https://doi.org/10.24237/04.04.615Keywords:
α-Klotho ,aging, thyroid gland ,hyperphosphatemia ,Vitamin DAbstract
Thyroid cancer and various endocrine disorders are associated with the multifunctional protein known as α-Klotho, also referred to as Klotho. However, nothing is known about the connection between blood Klotho levels and thyroid hormones. Additionally, mice homozygous for a hypomorphic Klotho gene (kl/kl) were the first to exhibit anti-aging capabilities. These mice show vascular calcification, cardiac hypertrophy, hypertension, pulmonary illness, renal disease, multi-organ atrophy, fibrosis, hyperphosphatemia, hypercalcemia, stunted development, and a shorter lifetime. Klotho overexpression has the opposite effect and lengthens life.
Klotho levels in people decrease with age, diabetes, Alzheimer's disease, chronic renal disease, and other illnesses. Although the brain, pancreas, and other tissues also generate it, the kidneys are the primary source. Human kidney function frequently declines with age, lowering Klotho levels. This is associated with a higher death risk from all causes, and a shortage of Klotho causes hyperphosphatemia and hypervitaminosis D. Interestingly, Klotho inhibits four pathways transforming growth factor β (TGF-β), insulin-like growth factor 1 (IGF-1), Wnt, and NF-κB that have been connected to aging in different ways.
cellular senescence, apoptosis, inflammation, immunological dysfunction, fibrosis, and neoplasia can all be brought on by these. Accordingly, preclinical Klotho treatment improved cancer, diabetes, cardiovascular, renal, and neurological illnesses. In this article, we give a summary of recent advancements in the molecular mechanisms of α-Klotho protein, elucidating the part that α-Klotho protein plays in thyroid dysfunction and pointing out areas that need more research.
Downloads
References
[1]
S. Javidnia, S. Cranwell, S. H. Mueller, C. Selman, J. M. Tullet, K. Kuchenbaecker, & N. Alic, “Mendelian randomization analyses implicate biogenesis of translation machinery in human aging”, Genome Research, 32(2), 258-265(2022), DOI: 10.1101/gr.275636.121
[2]
F. Coppedè, “Mutations involved in premature-ageing syndromes”, The application of clinical genetics, 279-295(2021), DOI: 10.2147/TACG.S273525
[3]
M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, T. Utsugi, Y. I. Nabeshima, “Mutation of the mouse klotho gene leads to a syndrome resembling ageing”, nature, 390(6655), 45-51(1997), DOI: 10.1038/36285
[4]
H. Tsujikawa, Y. Kurotaki, T. Fujimori, K. Fukuda, & Y. I. Nabeshima, “Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system”, Molecular endocrinology, 17(12), 2393-2403(2003), DOI: 10.1210/me.2003-0048
[5]
P. Buendía, J. Carracedo, S. Soriano, J. A. Madueño, A. Ortiz, A. Martín-Malo, R. Ramírez, “Klotho prevents NFκB translocation and protects endothelial cell from senescence induced by uremia”, Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 70(10), 1198-1209(2015), DOI: 10.1093/gerona/glu170
[6]
R. G. Erben, & O. Andrukhova, “FGF23-Klotho signaling axis in the kidney”, Bone, 100, 62-68(2017), DOI: 10.1016/j.bone.2016.09.010
[7]
S. Kinoshita, & M. Kawai, “The FGF23/KLOTHO regulatory network and its roles in human disorders”, Vitamins & Hormones, 101, 151-174(2016), DOI: 10.1016/bs.vh.2016.02.001
[8]
H. Kurosu, M. Yamamoto, J. D. Clark, J. V. Pastor, A. Nandi, P. Gurnani, M. Kuro-o, “Suppression of aging in mice by the hormone Klotho”, Science, 309(5742), 1829-1833(2005), DOI: 10.1126/science.1112766
[9]
G. D. Dalton, J. Xie, S. W. An, & C. L. Huang, “New insights into the mechanism of action of soluble klotho”, Frontiers in endocrinology, 8, 323(2017), DOI: 10.3389/fendo.2017.00323
[10]
M. Kuro-o, “The FGF23 and Klotho system beyond mineral metabolism”, Clinical and experimental nephrology, 21(Suppl 1), 64-69(2017), DOI: 10.1007/s10157-016-1357-6
[11]
I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, K. Okawa, T. Yamashita, “Klotho converts canonical FGF receptor into a specific receptor for FGF23”, Nature, 444(7120), 770-774(2006), DOI: 10.1038/nature05315
[12]
M. Kuro-o, “A potential link between phosphate and aging—lessons from Klotho-deficient mice”, Mechanisms of ageing and development, 131(4), 270-275(2010), DOI: 10.1016/j.mad.2010.02.008
[13]
V. N. Vasilkova, I. Y. Pchelin, Y. A. Borovets, I. A. Vasukhina, & T. V. Mokhort, “Clinical significance of the T (-344) C polymorphism of the aldosterone synthase gene (CYP11B2) in the prognosis of cardiorenal syndrome in diabetes mellitus”, Health and Ecology Issues, 19(4), 48-55.14(2023), DOI: https://doi.org/10.51523/2708-6011.2022-19-4-07
[14] M. Akl, & A. Ahmed, “Unveiling the Interplay of Klotho Protein, Chemotherapy-Induced Klotho Protein Deficiency, and the Pivotal Role of GLP-1 Agonists like Ozempic in Cancer Survivorship Patient Survival Rate after Chemotherapy Treatment”, 8 December (2023), DOI:10.32388/EPHLKX
[15]
J. H. Park, E. S. Noh, & I. T. Hwang, “α-Klotho levels in girls with central precocious puberty: potential as a diagnostic and monitoring marker”, Frontiers in Endocrinology, 15, 1383812(2024), DOI: 10.3389/fendo.2024.1383812
[16]
G. P. Dias, T. Murphy, D. Stangl, S. Ahmet, B. Morisse, A. Nix, S. Thuret, “Intermittent fasting enhances long-term memory consolidation, adult hippocampal neurogenesis, and expression of longevity gene Klotho”, Molecular psychiatry, 26(11), 6365-6379(2021), DOI:10.1038/s41380-021-01102-4
[17]
K. Lim, A. Groen, G. Molostvov, T. Lu, K. S. Lilley, D. Snead, D. Zehnder, “α-Klotho expression in human tissues”, The Journal of Clinical Endocrinology & Metabolism, 100(10), E1308-E1318(2015), DOI: 10.1210/jc.2015-1800
[18]
E. Martín-Núñez, A. Pérez-Castro, V. G. Tagua, C. Hernández-Carballo, C. Ferri, N. Pérez-Delgado, J. F. Navarro-González, “Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease”, Scientific Reports, 12(1), 8422(2022), DOI: 10.1038/s41598-022-12548-z
[19]
K. Lindberg, R. Amin, O. W. Moe, M. C. Hu, R. G. Erben, A. Ö. Wernerson, T. E. Larsson, “The kidney is the principal organ mediating klotho effects”, Journal of the American Society of Nephrology, 25(10), 2169-2175(2014) DOI: 10.1681/ASN.2013111209
[20]
M. C. Hu, M. Shi, J. Zhang, T. Addo, H. J. Cho, S. L. Barker, O. W. Moe, “Renal production, uptake, and handling of circulating αKlotho”, Journal of the American Society of Nephrology, 27(1), 79-90(2016), DOI: 10.1681/ASN.2014101030
[21]
S. C. Lim, J. J. Liu, T. Subramaniam, C. F. Sum, “Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients”, Journal of the Renin-Angiotensin-Aldosterone System, 15(4), 487-490(2014), DOI: https://doi.org/10.1177/1470320313475905
[22]
O. Andrukhova, U. Zeitz, R. Goetz, M. Mohammadi, B. Lanske, & R. G. Erben, “FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway”, Bone, 51(3), 621-628(2012), DOI: 10.1016/j.bone.2012.05.015
[23]
A. Takeshita, K. Kawakami, K. Furushima, M. Miyajima, & K. Sakaguchi, “Central role of the proximal tubular αKlotho/FGF receptor complex in FGF23-regulated phosphate and vitamin D metabolism”, Scientific reports, 8(1), 6917(2018), DOI: 10.1038/s41598-018-25087-3
[24]
Y. Xu, Z. Sun, "Molecular basis of Klotho: from gene to function in aging", Endocrine reviews, 36(2), 174-193(2015), DOI: 10.1210/er.2013-1079
[25]
G. Chen, Y. Liu, R. Goetz, L. Fu, S. Jayaraman, M. C. Hu, M. Mohammadi, “α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling”, Nature, 553(7689), 461-466(2018), DOI: https://doi.org/10.1038/nature25451
[26]
R. Mencke, G. Harms, J. Moser, M. van Meurs, A. Diepstra, H. G. Leuvenink, & J. L. Hillebrands, “Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease”, JCI insight, 2(20), (2017), https://doi.org/10.1172/jci.insight.94375
[27]
E. P. van Loon, W. P. Pulskens, E. A. van der Hagen, M. Lavrijsen, M. G. Vervloet, H. van Goor, J. G. Hoenderop, “Shedding of klotho by ADAMs in the kidney”, American Journal of Physiology-Renal Physiology, 309(4), F359-F368(2015), DOI: 10.1152/ajprenal.00240.2014
[28]
M. Bzowska, N. Jura, A. Lassak, R. A. Black, & J. Bereta, “Tumour necrosis factor‐α stimulates expression of TNF‐α converting enzyme in endothelial cells”, European Journal of Biochemistry, 271(13), 2808-2820(2004), DOI: https://doi.org/10.1111/j.1432-1033.2004.04215.x
[29]
X. Kuang, Y. S. Chen, L. F. Wang, Y. J. Li, K. Liu, M. X. Zhang, J. R. Du, “Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model”, Neurobiology of aging, 35(1), 169-178(2014), DOI: https://doi.org/10.1016/j.neurobiolaging.2013.07.019
[30]
S. E. Wu, & W. L. Chen, “Soluble klotho as an effective biomarker to characterize inflammatory states”, Annals of medicine, 54(1), 1520-1529(2022), DOI: https://doi.org/10.1080/07853890.2022.2077428
[31]
J. A. Moreno, M. C. Izquierdo, M. D. Sanchez-Nino, B. Suarez-Alvarez, C. Lopez-Larrea, A. Jakubowski, A. B. Sanz, “The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB”, Journal of the American Society of Nephrology, 22(7), 1315-1325(2011), DOI: 10.1681/ASN.2010101073
[32]
W. Lin, X. Wu, J. Wen, Y. Fei, J. Wu, X. Li, N. Wang, “Nicotinamide retains Klotho expression and ameliorates rhabdomyolysis-induced acute kidney injury”, Nutrition, 91, 111376(2021), DOI: https://doi.org/10.1016/j.nut.2021.111376
[33]
Q. Zhou, S. Lin, R. Tang, P. Veeraragoo, W. Peng, R. Wu, “Role of fosinopril and valsartan on klotho gene expression induced by angiotensin II in rat renal tubular epithelial cells”, Kidney and Blood Pressure Research, 33(3), 186-192(2010), DOI: https://doi.org/10.1159/000316703
[34]
H. Narumiya, S. Sasaki, N. Kuwahara, H. Irie, T. Kusaba, H. Kameyama, H. Matsubara, “HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells” Cardiovascular research, 64(2), 331-336(2004), DOI: https://doi.org/10.1016/j.cardiores.2004.07.011
[35]
M. Abolghasemi, T. Yousefi, M. Maniati, & D. Qujeq, “The interplay of Klotho with signaling pathway and microRNAs in cancers”, Journal of Cellular Biochemistry, 120(9), 14306-14317(2019), DOI: 10.1002/jcb.29022
[36]
J. Karalliedde, G. Maltese, B. Hill, G. Viberti, L. Gnudi, “Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria”, Clinical Journal of the American Society of Nephrology, 8(11), 1899-1905(2013), DOI: https://doi.org/10.2215/cjn.02700313
[37]
X. Cheng, Q. Zhou, S. Lin, & R. Wu, “Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats”, Zhong Nan Da Xue Xue Bao Yi Xue Ban, 35(10), 1048–1056(2010), https://doi.org/10.3969/j.issn.1672-7347.2010.10.004
[38]
X. Li & Q. Zhou, “Effect of valsartan on ultrastructure in the brain tissue and expression of Klotho gene in spontaneously hypertensive rats”, Zhong nan da xue xue bao. Yi xue ban, Journal of Central South University”, Medical Sciences, (2010), DOI: https://doi.org/10.3969/j.issn.1672-7347.2010.03.011
[39]
L. J. Chen, M. F. Cheng, P. M. Ku & J. W. Lin, “Rosiglitazone increases cerebral klotho expression to reverse baroreflex in type 1‐like diabetic rats”, BioMed research international, 2014(1), 309151(2014), DOI: https://doi.org/10.1155/2014/309151
[40]
L. Cheng, L. Zhang, J. Yang & L. Hao, “Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho”, Experimental and Therapeutic Medicine, 13(2), 467-474(2017), DOI: https://doi.org/10.3892/etm.2016.3996
[41]
M. R. Haussler, S. Livingston, Z. L. Sabir, C. A. Haussler, & P. W. Jurutka, “Vitamin D receptor mediates a myriad of biological actions dependent on its 1, 25‐dihydroxyvitamin D ligand: distinct regulatory themes revealed by induction of Klotho and fibroblast growth Factor‐23”, JBMR plus, 5(1), e10432(2021), DOI: https://doi.org/10.1002/jbm4.10432
[42]
M. Kuro-o, “The Klotho proteins in health and disease”, Nature Reviews Nephrology, 15(1), 27-44(2019), DOI: https://doi.org/10.1038/s41581-018-0078-3
[43]
C. Lerch, R. Shroff, M. Wan, L. Rees, H. Aitkenhead, I. Kaplan Bulut, & ESPN CKD-MBD working group Prytula A Bachetta J Haffner D Klaus G Geßner M Schmitt CP Stabouli S Reusz G Verrina E Groothoff J Tondel C Gamero MA Petrosyan E Bakkaloglu SA Dursun I Shroff R., “Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease“, Nephrol Dial Transplant., 33(12), 2208-2217(2018), DOI: https://doi.org/10.1093/ndt/gfy012
[44]
J. Xue, L. Wang, Z. Sun & C. Xing, “Basic research in diabetic nephropathy health care: A study of the renoprotective mechanism of metformin”, Journal of medical systems, 43, 1-13(2019), DOI: https://doi.org/10.1007/s10916-019-1412-4
[45]
W. Zhou, M. M. Chen, H. L. Liu, Z. L. Si, W. H. Wu, H. Jiang, Z. H. Zhang, “Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho”, Acta pharmacologica sinica, 43(10), 2609-2623(2022), DOI: https://doi.org/10.1038/s41401-022-00898-3
[46]
W. L. Kang & G. S. Xu, “Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy”, scientific reports, 6(1), 19979(2016), DOI: https://doi.org/10.1038/srep19979
[47]
D. Zou, W. Wu, Y. He, S. Ma & J. Gao, “The role of klotho in chronic kidney disease”, BMC nephrology, 19(1), 285(2018), DOI: https://doi.org/10.1186/s12882-018-1094-z
[48]
R. G. Erben, “Physiological actions of fibroblast growth factor-23”, Frontiers in endocrinology, 9, 267(2018), DOI: https://doi.org/10.3389/fendo.2018.00267
[49]
I. Z. Ben-Dov, H. Galitzer, V. Lavi-Moshayoff, R. Goetz, M. Kuro-o, M. Mohammadi, J. Silver, “The parathyroid is a target organ for FGF23 in rats”, The Journal of clinical investigation, 117(12), 4003-4008(2007), DOI: https://doi.org/10.1172/JCI32409
[50]
M. Kuro-o, “Klotho in health and disease”, Current opinion in nephrology and hypertension, 21(4), 362-368(2012), DOI: https://doi.org/10.1097/MNH.0b013e32835422ad
[51]
R. Anour, O. Andrukhova, E. Ritter, U. Zeitz & R. G. Erben, “Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo”, PloS one, 7(2), e31376(2012), DOI: https://doi.org/10.1371/journal.pone.0031376
[52]
R. Mathew, M. Pal Bhadra & U. Bhadra, “Insulin/insulin-like growth factor-1 signalling (IIS) based regulation of lifespan across species”, Biogerontology, 18, 35–53(2017), DOI: https://doi.org/10.1007/s10522-016-9670-8
[53]
S. C. Johnson, “Nutrient sensing, signaling and ageing: the role of IGF-1 and mTOR in ageing and age-related disease”, Biochemistry and Cell Biology of Ageing: Part I Biomedical Science-97, 49-97(2018), DOI: https://doi.org/10.1007/978-981-13-2835-0_3
[54]
P. Kapahi, M. Kaeberlein & M. Hansen, “Dietary restriction and lifespan: Lessons from invertebrate models”, Ageing research reviews, 39, 3-14(2017), DOI: https://doi.org/10.1016/j.arr.2016.12.005
[55]
H. T. Vo, A. M. Laszczyk & G. D. King, “Klotho, the key to healthy brain aging?”, Brain Plasticity, 3(2), 183-194(2018), DOI: https://doi.org/10.3233/BPL-170057
[56]
B. Xie, J. Zhou, G. Shu, D. C. Liu, J. Zhou, J. Chen & L. Yuan, “Restoration of klotho gene expression induces apoptosis and autophagy in gastric cancer cells: tumor suppressive role of klotho in gastric cancer”, Cancer cell international, 13, 1-10(2013), DOI: https://doi.org/10.1186/1475-2867-13-18
[57]
X. Zhou, Q. Yang, Y. Xie, J. Sun, J. Hu, P. Qiu, S. Wang, “Tetrahydroxystilbene glucoside extends mouse life span via upregulating neural klotho and downregulating neural insulin or insulin-like growth factor 1”, Neurobiology of aging, 36(3), 1462-1470(2015), DOI: https://doi.org/10.1016/j.neurobiolaging.2014.11.002
[58]
M. Yamamoto, J. D. Clark, J. V. Pastor, P. Gurnani, A. Nandi, H. Kurosu, M. Kuro-o, “Regulation of Oxidative Stress by the Anti-aging Hormone Klotho*♦”, Journal of Biological Chemistry, 280(45), 38029-38034(2005), DOI: https://doi.org/10.1074/jbc.M509039200
[59]
Y. Lin & Z. Sun, “In vivo pancreatic β-cell–specific expression of antiaging gene Klotho: a novel approach for preserving β-cells in type 2 diabetes”, Diabetes, 64(4), 1444-1458(2015), DOI: https://doi.org/10.2337/db14-0632
[60]
N. Keles, B. Dogan, M. Kalcik, M. Caliskan, N. N. Keles, F. Aksu, A. Oguz, “Is serum Klotho protective against atherosclerosis in patients with type 1 diabetes mellitus?”, Journal of diabetes and its complications, 30(1), 126-132(2016), DOI: https://doi.org/10.1016/j.jdiacomp.2015.09.013
[61]
F. Tarhani, G. Heidari & A. Nezami, “Evaluation of α-klotho level in insulin dependent diabetes mellitus (IDDM) children”, Journal of Pediatric Endocrinology and Metabolism, 33(6), 761-765(2020), DOI: https://doi.org/10.1515/jpem-2019-0591
[62]
N. Fountoulakis, G. Maltese, L. Gnudi & J. Karalliedde, “Reduced levels of anti-ageing hormone klotho predict renal function decline in type 2 diabetes”, The Journal of Clinical Endocrinology & Metabolism, 103(5), 2026-2032(2018), DOI: https://doi.org/10.1210/jc.2018-00004
[63]
A. W. Hart, N. Baeza, Å. Apelqvist & H. Edlund, “Attenuation of FGF signalling in mouse β-cells leads to diabetes”, Nature, 408(6814), 864-868(2000), DOI: https://doi.org/10.1038/35048589
[64]
Y. Lin & Z. Sun, “Antiaging gene klotho attenuates pancreatic β-cell apoptosis in type 1 diabetes”, Diabetes, 64(12), 4298-4311(2015), DOI: https://doi.org/10.2337/db15-0066
[65]
T. Rubinek, I. Wolf, “The role of alpha-klotho as a universal tumor suppressor”, Vitamins & Hormones, 101, 197-214(2016), DOI: https://doi.org/10.1016/bs.vh.2016.03.001
[66]
M. Abolghasemi, T. Yousefi, M. Maniati, D. Qujeq, “The interplay of Klotho with signaling pathway and microRNAs in cancers”, Journal of Cellular Biochemistry, 120(9), 14306-14317(2019), DOI: https://doi.org/10.1002/jcb.29022
[67]
F. Ewendt, M. Feger & M. Föller, “Role of fibroblast growth factor 23 (FGF23) and αKlotho in cancer”, Frontiers in Cell and Developmental Biology, 8, (2021), DOI: https://doi.org/10.3389/fcell.2020.601006
[68]
L. Abramovitz, T. Rubinek, H. Ligumsky, S. Bose, I. Barshack, C. Avivi, I. Wolf, “KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer”, Clinical Cancer Research, 17(13), 4254-4266(2011), DOI: https://doi.org/10.1158/1078-0432.CCR-10-2749
[69]
B. Sanz, H. Arrieta, C. Rezola-Pardo, A. Fernández-Atutxa, J. Garin-Balerdi, N. Arizaga, J. Irazusta, “Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents”, Scientific reports, 11, 9098(2021), DOI: https://doi.org/10.1038/s41598-021-88455-6
[70]
M. F. Cheng, L. J. Chen & J. T. Cheng, “Decrease of Klotho in the kidney of streptozotocin‐induced diabetic rats”, BioMed Research International, 2010(1), 513853(2010), DOI: https://doi.org/10.1155/2010/513853
[71]
M. C. Hu, M. Kuro-o & O. W. Moe, “Klotho and chronic kidney disease”, Phosphate and Vitamin D in Chronic Kidney Disease, 180, 47-63(2013), DOI: https://doi.org/10.1159/000346778
[72]
G. P. Dias, T. Murphy, D. Stangl, S. Ahmet, B. Morisse, A. Nix, S. ... & Thuret, “Intermittent fasting enhances long-term memory consolidation, adult hippocampal neurogenesis, and expression of longevity gene Klotho”, Molecular psychiatry, 26(11), 6365-6379(2021), DOI: https://doi.org/10.1038/s41380-021-01102-4
[73]
Driscoll, Y. Ma, C. L. Gallagher, S. C. Johnson, S. Asthana, B. P. Hermann, O. C. Okonkwo, “Age-related tau burden and cognitive deficits are attenuated in KLOTHO KL-VS heterozygotes", Erratum, (2021), DOI: https://doi.org/10.3233/JAD-219006
[74]
M. Laszczyk, S. Fox-Quick, H. T. Vo, D. Nettles, P. C. Pugh, L. Overstreet-Wadiche, G. D. King, “Klotho regulates postnatal neurogenesis and protects against age-related spatial memory loss”, Neurobiology of aging, 59, 41-54(2017), DOI: https://doi.org/10.1016/j.neurobiolaging.2017.07.008
[75]
N. Tasnim, P. Dutta, J. Nayeem, P. Masud, A. Ferdousi, A. S. Ghosh, A. T. Khan, “Osteoporosis, an inevitable circumstance of chronic kidney disease: a systematic review”, Cureus, 13(10), (2021), DOI: https://doi.org/10.7759/cureus.18488
[76]
S. Doi, Y. Zou, O. Togao, J. V. Pastor, G. B. John, L. Wang, M. Kuro-o, “Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice”, Journal of Biological Chemistry, 286(10), 8655-8665(2011), DOI: https://doi.org/10.1074/jbc.M110.174037
[77]
K. Chen, S. Wang, Q. W. Sun, B. Zhang, M. Ullah & Z. Sun, “Klotho deficiency causes heart aging via impairing the Nrf2-GR pathway”, Circulation research, 128(4), 492-507(2021), DOI: https://doi.org/10.1161/CIRCRESAHA.120.317348
[78]
C. Manrique, J. Habibi, A. R. Aroor, J. R. Sowers, G. Jia, M. R. Hayden, V. G. DeMarco, “Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice”, Cardiovascular Diabetology, 15, 1-11(2016), DOI: https://doi.org/10.1186/s12933-016-0414-5
[79]
A. Olejnik, A. Franczak, A. Krzywonos-Zawadzka, M. Kałużna-Oleksy & I. Bil-Lula, “The biological role of klotho protein in the development of cardiovascular diseases”, BioMed research international, 2018(1), 5171945(2018), DOI: https://doi.org/10.1155/2018/5171945
[80]
F. Wang & J. Zheng, “Association between serum alpha-Klotho and severe abdominal aortic calcification among civilians in the United States”, Nutrition, Metabolism and Cardiovascular Diseases, 32(6), 1485-1492(2022), DOI: https://doi.org/10.1016/j.numecd.2022.02.017
[81]
Q. Huang, Y. Chen, S. Shen, Y. Wang, L. Liu, S. Wu, J. Wu, “Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis”, Aging (Albany NY), 12(7), 5812(2020), DOI: https://doi.org/10.18632/aging.102978
[82]
T. Landry, D. Shookster & H. Huang, “Circulating α-klotho regulates metabolism via distinct central and peripheral mechanisms”, Metabolism, 121, 154819(2021), DOI: https://doi.org/10.1016/j.metabol.2021.154819
[83]
Y. Lin & Z. Sun, “Antiaging gene Klotho enhances glucose-induced insulin secretion by up-regulating plasma membrane levels of TRPV2 in MIN6 β-cells”, Endocrinology, 153(7), 3029-3039(2012), DOI: https://doi.org/10.1210/en.2012-1091
[84]
G. J. Prud'homme, Y. Glinka, M. Kurt, W. Liu & Q. Wang, “The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells”, Biochemical and biophysical research communications, 493(4), 1542-1547(2017), DOI: https://doi.org/10.1016/j.bbrc.2017.10.029
[85]
H. T. Vo, A. M. Laszczyk, & G. D. King, “Klotho, the key to healthy brain aging?”, Brain Plasticity, 3(2), 183-194(2018), DOI: https://doi.org/10.3233/BPL-170057
[86]
K. Hanson, K. Fisher & N. M. Hooper, “Exploiting the neuroprotective effects of α-klotho to tackle ageing-and neurodegeneration-related cognitive dysfunction”, Neuronal signaling, 5(2), NS20200101(2021), DOI: https://doi.org/10.1042/NS20200101
[87]
F. Veronesi, V. Borsari, A. Cherubini & M. Fini, “Association of Klotho with physical performance and frailty in middle-aged and older adults: A systematic review”, Experimental Gerontology, 154, 111518(2021), DOI: https://doi.org/10.1016/j.exger.2021.111518
[88]
T. Y. Fung, A. Iyaswamy, S. G. Sreenivasmurthy, S. Krishnamoorthi, X. J. Guan, Z. Zhu, M. Li, “Klotho an autophagy stimulator as a potential therapeutic target for Alzheimer’s disease: A review”, Biomedicines, 10(3), 705(2022), DOI: https://doi.org/10.3390/biomedicines10030705
[89]
R. Senese, F. Cioffi, G. Petito, F. Goglia & A. Lanni, “Thyroid hormone metabolites and analogues”, Endocrine, 66(1), 105-114(2019), DOI: https://doi.org/10.1007/s12020-019-02025-5
[90]
Y. Sun, P. F. Xia, T. I. M. Korevaar, V. Mustieles, Y. Zhang, X. F. Pan, C. Messerlian, “Relationship between blood trihalomethane concentrations and serum thyroid function measures in US adults”, Environmental Science & Technology, 55(20), 14087-14094(2021), DOI: https://doi.org/10.1021/acs.est.1c04008
[91]
P. N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J. H. Lazarus, C. M. Dayan & O. E. Okosieme, “Global epidemiology of hyperthyroidism and hypothyroidism”, Nature Reviews Endocrinology, 14(5), 301-316(2018), DOI: https://doi.org/10.1038/nrendo.2018.18
[92]
M. Babić Leko, N. Pleić, I. Gunjača & T. Zemunik, “Environmental factors that affect parathyroid hormone and calcitonin levels”, International journal of molecular sciences, 23(1), 44(2021), DOI: https://doi.org/10.3390/ijms23010044
[93]
C. L. Meuwese, H. Olauson, A. R. Qureshi, J. Ripsweden, P. Barany, C. Vermeer, P. Stenvinkel, “Associations between thyroid hormones, calcification inhibitor levels and vascular calcification in end-stage renal disease”, PloS one, 10(7), e0132353(2015), DOI: https://doi.org/10.1371/journal.pone.0132353
[94]
I. Mizuno, Y. Takahashi, Y. Okimura, H. Kaji & K. Chihara, “Upregulation of the klotho gene expression by thyroid hormone and during adipose differentiation in 3T3-L1 adipocytes”, Life sciences, 68(26), 2917-2923(2001), DOI: https://doi.org/10.1016/S0024-3205(01)01092-X
[95]
S. K. Soo, P. D. Rudich, A. Traa, N. Harris-Gauthier, H. J. Shields & J. M. Van Raamsdonk, “Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders”, Mechanisms of ageing and development, 190, 111297(2020), DOI: https://doi.org/10.1016/j.mad.2020.111297
[96]
M. R. Haussler, S. Livingston, Z. L. Sabir, C. A. Haussler & P. W. Jurutka, “Vitamin D receptor mediates a myriad of biological actions dependent on its 1”, 25‐dihydroxyvitamin D ligand: distinct regulatory themes revealed by induction of Klotho and fibroblast growth Factor‐23. JBMR plus, 5(1), e10432, (2021), DOI: https://doi.org/10.1002/jbm4.10432
[97]
M. F. Ali, S. K. B. Venkatarayappa, M. Benny, C. Rojas, K. Yousefi, L. A. Shehadeh, K. C. Young, “Effects of Klotho supplementation on hyperoxia-induced renal injury in a rodent model of postnatal nephrogenesis”, Pediatric research, 88(4), 565-570(2020), DOI: https://doi.org/10.1038/s41390-020-0803-z
[98]
T. H. Chen, M. Kuro-o, C. H. Chen, Y. M. Sue, Y. C. Chen, H. H. Wu, & C. Y. Cheng, “The secreted Klotho protein restores phosphate retention and suppresses accelerated aging in Klotho mutant mice”, European journal of pharmacology(1-3), 67-73(2013), DOI: https://doi.org/10.1016/j.ejphar.2012.09.032
[99]
H. J. Oh, B. Y. Nam, M. Wu, S. Kim, J. Park, S. Kang, S. H. Han, “Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy”, American Journal of Physiology-Renal Physiology, 315(4), F791-F805(2018), DOI: https://doi.org/10.1152/ajprenal.00462.2017
[100]
Z. Rao, T. Landry, P. Li, W. Bunner, B. T. Laing, Y. Yuan & H. Huang, “Administration of alpha klotho reduces liver and adipose lipid accumulation in obese mice”, Heliyon, 5(4), (2019), DOI: https://doi.org/10.1007/s13205-022-03123-4
[101]
Takenaka, H. Kobori, T. Inoue, T. Miyazaki, H. Suzuki, A. Nishiyama, M. Hayashi, “Klotho supplementation ameliorates blood pressure and renal function in DBA/2-pcy mice, a model of polycystic kidney disease”, American Journal of Physiology-Renal Physiology, 318(3), F557-F564(2020), DOI: https://doi.org/10.1152/ajprenal.00299.2019
[102]
T. Arbel Rubinstein, I. Reuveni, A. Hesin, A. Klein-Goldberg, H. Olauson, T. E. Larsson, T. Rubinek, “A transgenic model reveals the role of klotho in pancreatic cance”, (2021), DOI: https://doi.org/10.3390/cancers13246297
[103]
Y. J. Shin, K. Luo, Y. Quan, E. J. Ko, B. H. Chung, S. W. Lim & C. W. Yang, “Therapeutic challenge of minicircle vector encoding klotho in animal model”, American Journal of Nephrology, 49(5), 413-424(2019), DOI: https://doi.org/10.1159/000499863
[104]
S. S. Li, A. L. He, Z. Y. Deng & Q. F. Liu, “Ginsenoside-Rg1 protects against renal fibrosis by regulating the Klotho/TGF-β1/Smad signaling pathway in rats with obstructive nephropathy”, Biological and Pharmaceutical Bulletin, 41(4), 585-591(2018), DOI: https://doi.org/10.3389/fphar.2017.00362
[105]
T. Morishima & E. Ochi, “Impact of a single bout of resistance exercise on serum Klotho in healthy young men”, Physiological Reports, 9(21), e15087(2021), DOI: https://doi.org/10.14814/phy2.15087
[106]
F. J. Amaro-Gahete, A. de-la-O, L. Jurado-Fasoli, J. R. Ruiz, M. J. Castillo & Á. Gutiérrez, “Role of exercise on S-Klotho protein regulation: a systematic review”, Current aging science, 11(2), 100-107(2018), DOI: https://doi.org/10.2174/1874609811666180702101338
[107]
T. Arbel Rubinstein, I. Reuveni, A. Hesin, A. Klein-Goldberg, H. Olauson, T. E. Larsson, T. Rubinek, “A transgenic model reveals the role of klotho in pancreatic cance”, 13(24), 6297(2021), DOI: https://doi.org/10.3390/cancers13246297
[108]
Y. J. Shin, K. Luo, Y. Quan, E. J. Ko, B. H. Chung, S. W. Lim & C. W. Yang, “Therapeutic challenge of minicircle vector encoding klotho in animal model”, American Journal of Nephrology, 49(5), 413-424(2019), DOI: https://doi.org/10.1159/000499863
[109]
S. S. Li, A. L. He, Z. Y. Deng & Q. F. Liu, “Ginsenoside-Rg1 protects against renal fibrosis by regulating the Klotho/TGF-β1/Smad signaling pathway in rats with obstructive nephropathy”, Biological and Pharmaceutical Bulletin, 41(4), 585-591(2018), DOI: https://doi.org/10.3389/fphar.2017.00362
[110]
F. J. Amaro-Gahete, A. de-la-O, L. Jurado-Fasoli, J. R. Ruiz, M. J. Castillo & Á. Gutiérrez, “Role of exercise on S-Klotho protein regulation: a systematic review”, Current aging science,
Downloads
Published
Issue
Section
License
Copyright (c) 2026 CC BY 4.0
This work is licensed under a Creative Commons Attribution 4.0 International License.
